All Stories

  1. Fatty acid abnormalities in cystic fibrosis –the missing link for a cure?

    Article • iScience, October 2024, Elsevier

    Birgitta Strandvik

  2. Serum phospholipid fatty acids are associated with bone mass in healthy 4-years-old children.

    Article • Prostaglandins Leukotrienes and Essential Fatty Acids, December 2023, Elsevier

    Birgitta Strandvik

  3. Elevated plasma phospholipid n-3 docosapentaenoic acid concentrations during hibernation

    Article • PLOS One, June 2023, PLOS

    Birgitta Strandvik

  4. The fatty acid imbalance of cystic fibrosis exists at birth independent of feeding in pig and ferret models

    Article • Clinical Science, December 2022, Portland Press Ltd.

    Birgitta Strandvik

  5. Geographical distribution of cystic fibrosis carriers as population genetic determinant of COVID-19 spread and fatality in 37 countries

    Article • Journal of Infection, June 2022, Elsevier

    Birgitta Strandvik

  6. Omega-3 fatty acids decrease CRYAB, production of oncogenic prostaglandin E2 and suppress tumor growth in medulloblastoma

    Article • Life Sciences, April 2022, Elsevier

    Birgitta Strandvik

  7. Ursodeoxycholic acid and liver disease associated with cystic fibrosis: A multicenter cohort study

    Article • Journal of Cystic Fibrosis, March 2022, Elsevier

    Birgitta Strandvik

  8. Nutrition in Cystic Fibrosis—Some Notes on the Fat Recommendations

    Article • Nutrients, February 2022, MDPI AG

    Birgitta Strandvik

  9. Liver X receptor β regulates bile volume and the expression of aquaporins and cystic fibrosis transmembrane conductance regulator in the gallbladder

    Article • AJP Gastrointestinal and Liver Physiology, September 2021, American Physiological Society

    Birgitta Strandvik

  10. Body surface area-based omega-3 fatty acids supplementation strongly correlates to blood concentrations in children.

    Article • Prostaglandins Leukotrienes and Essential Fatty Acids, June 2021, Elsevier

    Birgitta Strandvik

  11. Is the ENaC Dysregulation in CF an Effect of Protein-Lipid Interaction in the Membranes?

    Article • International Journal of Molecular Sciences, March 2021, MDPI AG

    Birgitta Strandvik

  12. P059 A double-blind randomised multi-centre European study of linoleic acid supplementation for one year in patients with cystic fibrosis

    Article • Journal of Cystic Fibrosis, January 2021, Elsevier

    Birgitta Strandvik

  13. Abnormal n-6 fatty acid metabolism in cystic fibrosis contributes to pulmonary symptoms

    Article • Prostaglandins Leukotrienes and Essential Fatty Acids, September 2020, Elsevier

    Birgitta Strandvik

  14. Chapter 2. ESPGHAN: 50 Years Memories—The Early Years

    Article • Journal of Pediatric Gastroenterology and Nutrition, April 2018, Wolters Kluwer Health

    Birgitta Strandvik

  15. Chapter 8. 50 Years of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN): Captivating Witness Reports of a Success Story

    Article • Journal of Pediatric Gastroenterology and Nutrition, April 2018, Wolters Kluwer Health

    Birgitta Strandvik

  16. Low linoleic and high docosahexaenoic acids in a severe phenotype of transgenic cystic fibrosis mice

    Article • Experimental Biology and Medicine, March 2018, SAGE Publications

    Birgitta Strandvik

  17. Serum n-6 and n-9 Fatty Acids Correlate With Serum IGF-1 and Growth Up to 4 Months of Age in Healthy Infants

    Article • Journal of Pediatric Gastroenterology and Nutrition, January 2018, Wolters Kluwer Health

    Birgitta Strandvik

  18. 304 Severe phenotype of CF mice with low linoleic acid and high docosahexaenoic acid concentrations in serum phospholipids

    Article • Journal of Cystic Fibrosis, June 2017, Elsevier

    Birgitta Strandvik

  19. Highlights of the ESPEN-ESPGHAN-ECFS Guidelines on Nutrition Care for Infants and Children With Cystic Fibrosis

    Article • Journal of Pediatric Gastroenterology and Nutrition, December 2016, Wolters Kluwer Health

    Birgitta Strandvik

  20. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis

    Article • Clinical Nutrition, June 2016, Elsevier

    Birgitta Strandvik

  21. Long-chain saturated and monounsaturated fatty acids associate with development of premature infants up to 18 months of age

    Article • Prostaglandins Leukotrienes and Essential Fatty Acids, April 2016, Elsevier

    Birgitta Strandvik

  22. Antinociceptive fatty acid patterns differ in children with psychosomatic recurrent abdominal pain and healthy controls

    Article • Acta Paediatrica, March 2016, Wiley

    Birgitta Strandvik

  23. The development of infants born to obese mothers might be related to omega-3 fatty acid status

    Article • Acta Paediatrica, November 2015, Wiley

    Birgitta Strandvik

  24. Perinatal programming by diets with essential fatty acid deficient/high saturated fatty acids or different n-6/n-3 ratios for diseases in adulthood

    Article • European Journal of Lipid Science and Technology, August 2015, Wiley

    Birgitta Strandvik

  25. Lipid Quality in Infant Nutrition

    Article • Journal of Pediatric Gastroenterology and Nutrition, July 2015, Wolters Kluwer Health

    Birgitta Strandvik

  26. Can Lipidomics Conceal the Key for Understanding Celiac Disease?

    Article • Journal of Pediatric Gastroenterology and Nutrition, February 2015, Wolters Kluwer Health

    Birgitta Strandvik

  27. Dietary Fat and Fat Metabolism in CF

    Article • January 2015, Springer Science + Business Media

    Birgitta Strandvik

  28. Essential Fatty Acid Deficiency in Cystic Fibrosis

    Article • January 2015, Elsevier

    Birgitta Strandvik

  29. IL-1β expression in the distal lung epithelium disrupts lung morphogenesis and epithelial cell differentiation in fetal mice

    Article • AJP Lung Cellular and Molecular Physiology, January 2014, American Physiological Society

    Birgitta Strandvik

  30. Omega-6 and omega-3 fatty acids in milk and beneficial impact on the infant

    Article • September 2013, De Gruyter

    Birgitta Strandvik

  31. Nervonic acid is much lower in donor milk than in milk from mothers delivering premature infants—Of neglected importance?

    Article • Prostaglandins Leukotrienes and Essential Fatty Acids, September 2013, Elsevier

    Birgitta Strandvik

  32. Polyamine levels in breast milk are associated with mothers' dietary intake and are higher in preterm than full-term human milk and formulas

    Article • Journal of Human Nutrition and Dietetics, August 2013, Wiley

    Birgitta Strandvik

  33. Lower polyamine levels in breast milk of obese mothers compared to mothers with normal body weight

    Article • Journal of Human Nutrition and Dietetics, April 2013, Wiley

    Birgitta Strandvik

  34. Different fatty acid pattern in breast milk of obese compared to normal-weight mothers

    Article • Prostaglandins Leukotrienes and Essential Fatty Acids, March 2013, Elsevier

    Birgitta Strandvik

  35. Relation Between Dietary Fat Intake Type and Serum Fatty Acid Status in Children With Cystic Fibrosis

    Article • Journal of Pediatric Gastroenterology and Nutrition, November 2012, Wolters Kluwer Health

    Birgitta Strandvik

  36. 243 IMPACT OF CHILDHOOD SOCIOECONOMIC STATUS ON SERUM LEVEL OF OMEGA-3 FATTY ACIDS AND CARDIOVASCULAR RISK FACTORS IN HEALTHY ADOLESCENTS. A 3-YEAR FOLLOW-UP STUDY

    Article • Journal of Hypertension, September 2012, Wolters Kluwer Health

    Birgitta Strandvik

  37. Reasons given by mothers for discontinuing breastfeeding in Iran

    Article • International Breastfeeding Journal, May 2012, Springer Science + Business Media

    Birgitta Strandvik

  38. Motor, mental and behavioral developments in infancy are associated with fatty acid pattern in breast milk and plasma of premature infants

    Article • Prostaglandins Leukotrienes and Essential Fatty Acids, April 2012, Elsevier

    Birgitta Strandvik

  39. High Physiological Omega-3 Fatty Acid Supplementation Affects Muscle Fatty Acid Composition and Glucose and Insulin Homeostasis in Obese Adolescents

    Article • Journal of Nutrition and Metabolism, January 2012, Hindawi Publishing Corporation

    Birgitta Strandvik

  40. Response to the letter by Ooi et al.

    Article • Journal of Cystic Fibrosis, January 2012, Elsevier

    Birgitta Strandvik

  41. The omega-6/omega-3 ratio is of importance!

    Article • Prostaglandins Leukotrienes and Essential Fatty Acids, December 2011, Elsevier

    Birgitta Strandvik

  42. Early behavior and development are influenced by the n-6 and n-3 status in prematures

    Article • Oléagineux Corps gras Lipides, November 2011, EDP Sciences

    Birgitta Strandvik

  43. Postnatal essential fatty acid deficiency in mice affects lipoproteins, hepatic lipids, fatty acids and mRNA expression

    Article • Prostaglandins Leukotrienes and Essential Fatty Acids, September 2011, Elsevier

    Birgitta Strandvik

  44. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease

    Article • Journal of Cystic Fibrosis, June 2011, Elsevier

    Birgitta Strandvik

  45. New clinical diagnostic procedures for cystic fibrosis in Europe

    Article • Journal of Cystic Fibrosis, June 2011, Elsevier

    Birgitta Strandvik

  46. Prenatal essential fatty acid deficiency in mice results in long-term gender-specific effects on body weight and glucose metabolism

    Article • Molecular Medicine Reports, May 2011, Spandidos Publications

    Birgitta Strandvik

  47. Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease

    Article • Hepatology, March 2011, Wiley

    Birgitta Strandvik

  48. Postnatal deficiency of essential fatty acids in mice results in resistance to diet-induced obesity and low plasma insulin during adulthood

    Article • Prostaglandins Leukotrienes and Essential Fatty Acids, March 2011, Elsevier

    Birgitta Strandvik

  49. The skinny on tuna fat: health implications

    Article • Public Health Nutrition, February 2011, Cambridge University Press

    Birgitta Strandvik

  50. From the Swedish to the Mediterranean Diet and the Omega-6/Omega-3 Balance

    Article • January 2011, Karger Publishers

    Birgitta Strandvik

  51. Optimal vitamin A and suboptimal vitamin D status are common in Iranian infants

    Article • Acta Paediatrica, November 2010, Wiley

    Birgitta Strandvik

  52. Omega-3 fatty acid supplementation improves vascular function and reduces inflammation in obese adolescents

    Article • Atherosclerosis, October 2010, Elsevier

    Birgitta Strandvik

  53. Inverse relation between vitamin D and serum total immunoglobulin G in the Scandinavian Cystic Fibrosis Nutritional Study

    Article • European Journal of Clinical Nutrition, September 2010, Springer Science + Business Media

    Birgitta Strandvik

  54. Fatty acid metabolism in cystic fibrosis

    Article • Prostaglandins Leukotrienes and Essential Fatty Acids, September 2010, Elsevier

    Birgitta Strandvik

  55. High levels of soluble intercellular adhesion molecule-1, insulin resistance and saturated fatty acids are associated with endothelial dysfunction in healthy adolescents

    Article • Atherosclerosis, August 2010, Elsevier

    Birgitta Strandvik

  56. Early behaviour and development in breast-fed premature infants are influenced by omega-6 and omega-3 fatty acid status

    Article • Early Human Development, July 2010, Elsevier

    Birgitta Strandvik

  57. Food choice is reflected in serum markers and anthropometric measures in healthy 8-yr-olds

    Article • e-SPEN the European e-Journal of Clinical Nutrition and Metabolism, June 2010, Elsevier

    Birgitta Strandvik

  58. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD

    Article • Acta Paediatrica, May 2010, Wiley

    Birgitta Strandvik

  59. Supplementation With Fatty Acids Influences the Airway Nitric Oxide and Inflammatory Markers in Patients With Cystic Fibrosis

    Article • Journal of Pediatric Gastroenterology and Nutrition, May 2010, Wolters Kluwer Health

    Birgitta Strandvik

  60. Fatty acid composition of diet, cord blood and breast milk in Chinese mothers with different dietary habits

    Article • Prostaglandins Leukotrienes and Essential Fatty Acids, November 2009, Elsevier

    Birgitta Strandvik

  61. Metabolic profiles of fat and glucose differ by gender in healthy 8-year-olds

    Article • Acta Paediatrica, September 2009, Wiley

    Birgitta Strandvik

  62. Heart rate recovery in young adult patients with cystic fibrosis

    Article • Journal of Cystic Fibrosis, June 2009, Elsevier

    Birgitta Strandvik

  63. Processed animal products with emphasis on polyunsaturated fatty acid content

    Article • European Journal of Lipid Science and Technology, May 2009, Wiley

    Birgitta Strandvik

  64. Ezrin-Radixin-Moesin-Binding Phosphoprotein (EBP50), an Estrogen-Inducible Scaffold Protein, Contributes to Biliary Epithelial Cell Proliferation

    Article • American Journal Of Pathology, March 2009, Elsevier

    Birgitta Strandvik

  65. Fatty acid pattern in serum is associated with bone mineralisation in healthy 8-year-old children

    Article • British Journal Of Nutrition, January 2009, Cambridge University Press

    Birgitta Strandvik

  66. Breastfeeding in Iran: prevalence, duration and current recommendations

    Article • International Breastfeeding Journal, January 2009, Springer Science + Business Media

    Birgitta Strandvik

  67. Fatty acid patterns early after premature birth, simultaneously analysed in mothers' food, breast milk and serum phospholipids of mothers and infants

    Article • Lipids in Health and Disease, January 2009, Springer Science + Business Media

    Birgitta Strandvik

  68. Liver function and morphology during long-term fatty acid supplementation in cystic fibrosis

    Article • Liver International, December 2008, Wiley

    Birgitta Strandvik

  69. Liver damage in juvenile inflammatory bowel disease

    Article • Liver International, December 2008, Wiley

    Birgitta Strandvik

  70. Serum Linoleic Acid Status as a Clinical Indicator of Essential Fatty Acid Status in Children With Cystic Fibrosis

    Article • Journal of Pediatric Gastroenterology and Nutrition, November 2008, Wolters Kluwer Health

    Birgitta Strandvik

  71. Volumetric bone mineral density is an important tool when interpreting bone mineralization in healthy children

    Article • Acta Paediatrica, October 2008, Wiley

    Birgitta Strandvik

  72. SUPPLEMENT WITH OMEGA 3 FATTY ACIDS IMPROVES ENDOTHELIAL FUNCTION IN OBESE ADOLESCENTS

    Article • Atherosclerosis Supplements, May 2008, Elsevier

    Birgitta Strandvik

  73. Is the relatively low intake of omega‐3 fatty acids in Western diet contributing to the obesity epidemics?

    Article • Lipid Technology, March 2008, Wiley

    Birgitta Strandvik

  74. Muscular strength after different types of training in physically active patients with cystic fibrosis

    Article • Scandinavian Journal of Medicine and Science in Sports, January 2008, Wiley

    Birgitta Strandvik

  75. Cardiopulmonary Data in Response to 6 Months of Training in Physically Active Adult Patients with Classic Cystic Fibrosis

    Article • Respiration, January 2008, Karger Publishers

    Birgitta Strandvik

  76. Fatty acid composition in breast milk and serum phospholipids of healthy term Chinese infants during first 6 weeks of life

    Article • Acta Paediatrica, November 2007, Wiley

    Birgitta Strandvik

  77. Abstract 3646: Supplement with Omega-3 Fatty Acids Lowers Pulse Wave Velocity in Obese Adolescents

    Article • Circulation, October 2007, Wolters Kluwer Health

    Birgitta Strandvik

  78. Dornase alfa is well tolerated: Data from the Epidemiologic Registry of Cystic Fibrosis

    Article • Pediatric Pulmonology, August 2007, Wiley

    Birgitta Strandvik

  79. Docosahexaenoic acid is associated with endosteal circumference in long bones in young males with cystic fibrosis

    Article • British Journal Of Nutrition, August 2007, Cambridge University Press

    Birgitta Strandvik

  80. 235 Serum vitamin E and IL-6 are influenced by type of physical training in patients with CF

    Article • Journal of Cystic Fibrosis, June 2007, Elsevier

    Birgitta Strandvik

  81. Airway Nitric Oxide in Patients With Cystic Fibrosis Is Associated With Pancreatic Function, Pseudomonas Infection, and Polyunsaturated Fatty Acids

    Article • CHEST Journal, June 2007, Elsevier

    Birgitta Strandvik

  82. Food choice, socio-economic characteristics and health in 4-year olds in a well-educated urban Swedish community

    Article • Clinical Nutrition, February 2007, Elsevier

    Birgitta Strandvik

  83. Swedish pre-school children eat too much junk food and sucrose

    Article • Acta Paediatrica, February 2007, Wiley

    Birgitta Strandvik

  84. Epithelial Electrical Resistance as a Measure of Permeability Changes in Pediatric Duodenal Biopsies

    Article • Journal of Pediatric Gastroenterology and Nutrition, November 2006, Wolters Kluwer Health

    Birgitta Strandvik

  85. Metabolic markers in relation to nutrition and growth in healthy 4-y-old children in Sweden

    Article • American Journal of Clinical Nutrition, November 2006, Oxford University Press (OUP)

    Birgitta Strandvik

  86. Serum Phospholipid Fatty Acids, Adipose Tissue, and Metabolic Markers in Obese Adolescents*

    Article • Obesity, November 2006, Wiley

    Birgitta Strandvik

  87. LINOLEIC ACID STATUS FOR THE DIAGNOSIS OF ESSENTIAL FATTY ACID DEFICIENCY IN CHILDREN WITH CYSTIC FIBROSIS

    Article • Journal of Pediatric Gastroenterology and Nutrition, October 2006, Wiley

    Birgitta Strandvik

  88. Abnormal Fatty Acid Pattern in Intestinal Mucosa of Children With Celiac Disease Is Not Reflected in Serum Phospholipids

    Article • Journal of Pediatric Gastroenterology and Nutrition, September 2006, Wolters Kluwer Health

    Birgitta Strandvik

  89. Mediterranean diet and cystic fibrosis

    Article • British Journal Of Nutrition, August 2006, Cambridge University Press

    Birgitta Strandvik

  90. Serum phospholipid fatty acid pattern is associated with bone mineral density in children, but not adults, with cystic fibrosis

    Article • British Journal Of Nutrition, June 2006, Cambridge University Press

    Birgitta Strandvik

  91. 312 EBP50, a scaffold protein participating in the proliferation of cholangiocytes, is delocalized in the ductular reaction associated with cystic fibrosis liver disease

    Article • Journal of Hepatology, April 2006, Elsevier

    Birgitta Strandvik

  92. Mediterranean-inspired diet lowers the ratio of serum phospholipid n–6 to n–3 fatty acids, the number of leukocytes and platelets, and vascular endothelial growth factor in healthy subjects

    Article • American Journal of Clinical Nutrition, March 2006, Oxford University Press (OUP)

    Birgitta Strandvik

  93. Die Versorgung von Mukoviszidose-Patienten

    Article • Annales Nestlé (Deutsche Ausg ), January 2006, Karger Publishers

    Birgitta Strandvik

  94. Care of Patients with Cystic Fibrosis

    Article • Annales Nestlé (English ed ), January 2006, Karger Publishers

    Birgitta Strandvik

  95. Perinatal PUFA Intake Affects Leptin and Oral Tolerance in Neonatal Rats and Possibly Immunoreactivity in Intrauterine Growth Retardation in Man

    Article • January 2006, Karger Publishers

    Birgitta Strandvik

  96. 212 Working capacity and lung function in physically active patients with Cystic Fibrosis were unchanged after 6 months of training

    Article • Journal of Cystic Fibrosis, January 2006, Elsevier

    Birgitta Strandvik

  97. 280 Serum phospholipid fatty acid pattern is associated with bone growth in children but not adults with Cystic Fibrosis

    Article • Journal of Cystic Fibrosis, January 2006, Elsevier

    Birgitta Strandvik

  98. Asistencia de pacientes con fibrosis quística

    Article • Annales Nestlé (Ed española), January 2006, Karger Publishers

    Birgitta Strandvik

  99. Soins des patients atteints d’une mucoviscidose

    Article • Annales Nestlé (Ed française), January 2006, Karger Publishers

    Birgitta Strandvik

  100. Trampolines are Useful in the Treatment of Cystic Fibrosis Patients

    Article • Pediatric Pulmonology, November 2005, Wiley

    Birgitta Strandvik

  101. ESSENTIAL FATTY ACID DEFICIENCY AND THE CLINICAL RELEVANCE OF THE TRIENE:TETRAENE RATIO IN CHILDREN WITH CYSTIC FIBROSIS

    Article • Journal of Pediatric Gastroenterology and Nutrition, October 2005, Wiley

    Birgitta Strandvik

  102. Ultraviolet B radiation improves serum levels of vitamin D in patients with cystic fibrosis

    Article • Acta Paediatrica, May 2005, Wiley

    Birgitta Strandvik

  103. Muscular Strength and Function in Patients With Cystic Fibrosis

    Article • CHEST Journal, May 2005, Elsevier

    Birgitta Strandvik

  104. Cost-Effectiveness of Alendronate in the Prevention of Osteoporotic Fractures in Danish Women

    Article • Basic & Clinical Pharmacology & Toxicology, May 2005, Wiley

    Birgitta Strandvik

  105. DISTURBED PHOSPHOLIPID FATTY ACID PATTERN IN INTESTINAL BIOPSIES FROM PATIENTS WITH COELIAC DISEASE

    Article • Journal of Pediatric Gastroenterology and Nutrition, May 2005, Wiley

    Birgitta Strandvik

  106. MARKED CHANGES IN THE MRNA EXPRESSION OF PPARS IN THE LIVER OF MICE WITH PERINATAL ESSENTIAL FATTY ACID DEFICIENCY

    Article • Journal of Pediatric Gastroenterology and Nutrition, May 2005, Wiley

    Birgitta Strandvik

  107. Gender-related long-term effects in adult rats by perinatal dietary ratio of n-6/n-3 fatty acids

    Article • AJP Regulatory Integrative and Comparative Physiology, March 2005, American Physiological Society

    Birgitta Strandvik

  108. Cysteinyl leukotrienes are secretagogues in atrophic coeliac and in normal duodenal mucosa of children

    Article • Scandinavian Journal of Gastroenterology, February 2005, Taylor & Francis

    Birgitta Strandvik

  109. Perinatal essential fatty acid deficiency influences body weight and bone parameters in adult male rats

    Article • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, January 2005, Elsevier

    Birgitta Strandvik

  110. Dietary n-6:n-3 fatty acid ratio in the perinatal period affects bone parameters in adult female rats

    Article • British Journal Of Nutrition, October 2004, Cambridge University Press

    Birgitta Strandvik

  111. The ratio of n-6 to n-3 fatty acids in maternal diet influences the induction of neonatal immunological tolerance to ovalbumin

    Article • Clinical & Experimental Immunology, August 2004, Wiley

    Birgitta Strandvik

  112. Normal Annual Increase of Bone Mineral Density During Two Years in Patients With Cystic Fibrosis

    Article • PEDIATRICS, July 2004, American Academy of Pediatrics (AAP)

    Birgitta Strandvik

  113. Modulation of neonatal immunological tolerance to ovalbumin by maternal essential fatty acid intake

    Article • Pediatric Allergy and Immunology, April 2004, Wiley

    Birgitta Strandvik

  114. Duodenogastric Bile Reflux Is Common in Cystic Fibrosis

    Article • Journal of Pediatric Gastroenterology and Nutrition, March 2004, Wolters Kluwer Health

    Birgitta Strandvik

  115. Severe Hypercholesterolaemia Leads to Strong Th2 Responses to an Exogenous Antigen

    Article • Scandinavian Journal of Immunology, March 2004, Wiley

    Birgitta Strandvik

  116. Fatty Acid Metabolism in Cystic Fibrosis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, February 2004, New England Journal of Medicine (NEJM/MMS)

    Birgitta Strandvik

  117. Association between serum oncofetal antigens CA 19-9 and CA 125 and clinical status in patients with cystic fibrosis

    Article • Acta Paediatrica, November 2003, Wiley

    Birgitta Strandvik

  118. Dornase alfa in the treatment of cystic fibrosis in Europe: A report from the Epidemiologic Registry of Cystic Fibrosis

    Article • Pediatric Pulmonology, September 2003, Wiley

    Birgitta Strandvik

  119. The Transfer of Immunity from Mother to Child

    Article • Annals of the New York Academy of Sciences, April 2003, Wiley

    Birgitta Strandvik

  120. Decreased bone mineral density in normal-growing patients with cystic fibrosis

    Article • Acta Paediatrica, January 2003, Wiley

    Birgitta Strandvik

  121. Leptin levels in rat offspring are modified by the ratio of linoleic to α-linolenic acid in the maternal diet

    Article • Journal of Lipid Research, October 2002, Elsevier

    Birgitta Strandvik

  122. Breast-feeding, a complex support system for the offspring

    Article • Pediatrics International, August 2002, Wiley

    Birgitta Strandvik

  123. Breast‐feeding, a complex support system for the offspring

    Article • Pediatrics International, August 2002, Wiley

    Birgitta Strandvik

  124. Maternal Dietary Intake of Essential Fatty Acids Affects Adipose Tissue Growth and Leptin mRNA Expression in Suckling Rat Pups

    Article • Pediatric Research, July 2002, Springer Science + Business Media

    Birgitta Strandvik

  125. Predictors of deterioration of lung function in cystic fibrosis*

    Article • Pediatric Pulmonology, May 2002, Wiley

    Birgitta Strandvik

  126. Electrogenic Ion Transport in Duodenal Biopsies from Children with Coeliac Disease

    Article • Scandinavian Journal of Gastroenterology, January 2002, Taylor & Francis

    Birgitta Strandvik

  127. Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis

    Article • The Journal of Pediatrics, November 2001, Elsevier

    Birgitta Strandvik

  128. Presence of cystic fibrosis‐related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: Data from the European Epidemiologic Registry of Cystic Fibrosis

    Article • Pediatric Pulmonology, November 2001, Wiley

    Birgitta Strandvik

  129. Water‐miscible tocopherol is not superior to fat‐soluble preparation for vitamin E absorption in cystic fibrosis

    Article • Acta Paediatrica, October 2001, Wiley

    Birgitta Strandvik

  130. Water-miscible tocopherol is not superior to fat-soluble preparation for vitamin E absorption in cystic fibrosis

    Article • Acta Paediatrica, October 2001, Wiley

    Birgitta Strandvik

  131. Spectrum of Mutations in theCFTRGene of Patients with Classical and Atypical Forms of Cystic Fibrosis from Southwestern Sweden: Identification of 12 Novel Mutations

    Article • Genetic Testing, September 2001, Mary Ann Liebert Inc

    Birgitta Strandvik

  132. Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF

    Article • European Respiratory Journal, August 2001, European Respiratory Society (ERS)

    Birgitta Strandvik

  133. Gastric IgA in Cystic Fibrosis in Relation to the Migrating Motor Complex

    Article • Scandinavian Journal of Gastroenterology, August 2001, Taylor & Francis

    Birgitta Strandvik

  134. Allergic bronchopulmonary aspergillosis in cystic fibrosis

    Article • European Respiratory Journal, May 2001, European Respiratory Society (ERS)

    Birgitta Strandvik

  135. Maternal essential fatty acid deficiency depresses serum leptin levels in suckling rat pups

    Article • Journal of Lipid Research, March 2001, Elsevier

    Birgitta Strandvik

  136. Gastric Secretion in Cystic Fibrosis in Relation to the Migrating Motor Complex

    Article • Scandinavian Journal of Gastroenterology, February 2001, Taylor & Francis

    Birgitta Strandvik

  137. European Epidemiologic Registry of Cystic Fibrosis (ERCF): Comparison of major disease manifestations between patients with different classes of mutations

    Article • Pediatric Pulmonology, January 2001, Wiley

    Birgitta Strandvik

  138. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study

    Article • European Respiratory Journal, September 2000, European Respiratory Society (ERS)

    Birgitta Strandvik

  139. Essential fatty acid deficiency affects the fatty acid composition of the rat small intestinal and colonic mucosa differently

    Article • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, September 2000, Elsevier

    Birgitta Strandvik

  140. Diagnostic test meal in childhood enteropathy using simultaneous carbohydrate and fat loading

    Article • Acta Paediatrica, August 2000, Wiley

    Birgitta Strandvik

  141. Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis

    Article • Hepatology, August 2000, Wiley

    Birgitta Strandvik

  142. Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene: a cystic fibrosis mutation of Slavic origin common in Central and East Europe

    Article • Human Genetics, March 2000, Springer Science + Business Media

    Birgitta Strandvik

  143. Electrogenic Ion Transport in Duodenum, an Aid in Cystic Fibrosis Diagnosis

    Article • Scandinavian Journal of Gastroenterology, January 2000, Taylor & Francis

    Birgitta Strandvik

  144. Nutritional management in cystic fibrosis

    Article • Näringsforskning, December 1999, Taylor & Francis

    Birgitta Strandvik

  145. Natural history of liver disease in cystic fibrosis

    Article • Hepatology, November 1999, Wiley

    Birgitta Strandvik

  146. Composition and permeability of syncytiotrophoblast plasma membranes in pregnancies complicated by intrauterine growth restriction

    Article • Biochimica et Biophysica Acta (BBA) - Biomembranes, August 1999, Elsevier

    Birgitta Strandvik

  147. Allergy to laboratory animals in children of parents occupationally exposed to mice, rats and hamsters

    Article • European Respiratory Journal, August 1999, European Respiratory Society (ERS)

    Birgitta Strandvik

  148. Therapeutic drug monitoring in patients with cystic fibrosis and mycobacterial disease

    Article • European Respiratory Journal, August 1999, European Respiratory Society (ERS)

    Birgitta Strandvik

  149. 17. Eight new mutations identified at the West Swedish CF-center

    Article • The Netherlands Journal of Medicine, June 1999, Elsevier

    Birgitta Strandvik

  150. 65. Totally implantable venous access in patients with cystic fibrosis (CF)

    Article • The Netherlands Journal of Medicine, June 1999, Elsevier

    Birgitta Strandvik

  151. E2.1 Risk factors of importance for long-term survival of patients with cystic fibrosis

    Article • The Netherlands Journal of Medicine, June 1999, Elsevier

    Birgitta Strandvik

  152. E2.3 The European Epidemiological Registry of Cystic Fibrosis (ERCF). Does pulmozyme make any difference?

    Article • The Netherlands Journal of Medicine, June 1999, Elsevier

    Birgitta Strandvik

  153. CHLORIDE SECRETION IN DUODENUM, AN AID IN CYSTIC FIBROSIS (CF) DIAGNOSIS

    Article • Journal of Pediatric Gastroenterology and Nutrition, May 1999, Wolters Kluwer Health

    Birgitta Strandvik

  154. BILE ACID REGURGITATION INTO THE STOMACH IS A COMMON FINDING IN CYSTIC FIBROSIS (CF)

    Article • Journal of Pediatric Gastroenterology and Nutrition, May 1999, Wiley

    Birgitta Strandvik

  155. GASTRIC IgA IN CYSTIC FIBROSIS (CF) IN RELATION TO MIGRATING MOTOR COMPLEXES (MMC)

    Article • Journal of Pediatric Gastroenterology and Nutrition, May 1999, Wiley

    Birgitta Strandvik

  156. Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease

    Article • Pediatric Pulmonology, September 1998, Wiley

    Birgitta Strandvik

  157. RAT SERUM ARCHIDONIC ACID DECLINES DURING THE LACTATION PERIOD

    Article • Journal of Pediatric Gastroenterology and Nutrition, May 1998, Wolters Kluwer Health

    Birgitta Strandvik

  158. ESSENTIAL FATTY ACID DEFICIENCY DIFFERENTLY AFFECTS THE FATTY ACID COMPOSITION OF THE RAT INTESTINAL AND COLONIC MUCOSA.

    Article • Journal of Pediatric Gastroenterology and Nutrition, May 1998, Wiley

    Birgitta Strandvik

  159. PROSPECTIVE STUDY OF LIVER DISEASE FOR 15 YEARS IN CYSTIC FIBROSIS (CF)

    Article • Journal of Pediatric Gastroenterology and Nutrition, May 1998, Wiley

    Birgitta Strandvik

  160. URINARY BILE ACID EXCTRETION PATTERN IN CHILDREN WITH AAGENAES SYNDROME

    Article • Journal of Pediatric Gastroenterology and Nutrition, May 1998, Wiley

    Birgitta Strandvik

  161. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease

    Article • Hepatology, January 1998, Wiley

    Birgitta Strandvik

  162. Intestinal Permeability in Cystic Fibrosis in Relation to Genotype

    Article • Journal of Pediatric Gastroenterology and Nutrition, September 1997, Wolters Kluwer Health

    Birgitta Strandvik

  163. Reply to Angelico

    Article • Journal of Hepatology, May 1997, Elsevier

    Birgitta Strandvik

  164. EFFECTS OF ARACHIDONIC ACID METABOLITES ON RECTAL ION TRANSPORT IN ULCERATIVE COLITIS

    Article • Journal of Pediatric Gastroenterology and Nutrition, April 1997, Wiley

    Birgitta Strandvik

  165. Vitamin A Concentration in the Liver Decreases with Age in Patients with Cystic Fibrosis

    Article • Journal of Pediatric Gastroenterology and Nutrition, March 1997, Wolters Kluwer Health

    Birgitta Strandvik

  166. Electrogenic Ion Transport along the Human Duodenum in Childhood

    Article • Scandinavian Journal of Gastroenterology, January 1997, Taylor & Francis

    Birgitta Strandvik

  167. Prostanoid biosynthesis in patients with cystic fibrosis

    Article • Prostaglandins Leukotrienes and Essential Fatty Acids, December 1996, Elsevier

    Birgitta Strandvik

  168. Bile acid kinetics and biliary lipid composition in cystic fibrosis

    Article • Journal of Hepatology, July 1996, Elsevier

    Birgitta Strandvik

  169. Cystic Fibrosis Pulmonary Infection: The Swedish Experience

    Article • January 1996, Springer Science + Business Media

    Birgitta Strandvik

  170. Metabolism of orally fed [3H]-eicosapentaenoic and [14C]-arachidonic acid in essential fatty acid-deficient rats

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 1996, Taylor & Francis

    Birgitta Strandvik

  171. Leukotriene B4 and C4 Metabolism in Small Intestine Mucosa of Children with Celiac Disease

    Article • Journal of Pediatric Gastroenterology and Nutrition, November 1995, Wolters Kluwer Health

    Birgitta Strandvik

  172. Leukotriene B4and C4generation by human leukocytes after ex vivo stimulation with Ca-ionophore and opsonized zymosan in children with atopic asthma

    Article • Pediatric Allergy and Immunology, August 1995, Wiley

    Professor Göran Wennergren, Birgitta Strandvik

  173. 51 INTESTINAL PERMEABILITY IN CYSTIC FIBROSIS (CF) IN RELATION TO GENOTYPE AND ESSENTIAL FATTY ACID DEFICIENCY (EFAD)

    Article • Journal of Pediatric Gastroenterology and Nutrition, May 1995, Wiley

    Birgitta Strandvik

  174. 52 ESSENTIAL FATTY ACID DEFICIENCY (EFAD) IN RELATION TO GENOTYPE IN CYSTIC FIBROSIS (CF)

    Article • Journal of Pediatric Gastroenterology and Nutrition, May 1995, Wiley

    Birgitta Strandvik

  175. Incidence of liver disease in patients with cystic fibrosis and meconium ileus

    Article • The Journal of Pediatrics, January 1995, Elsevier

    Birgitta Strandvik

  176. Defective inhibition by dexamethasone of leukotriene B4 and C4 production by leukocytes in patients with cystic fibrosis

    Article • Prostaglandins Leukotrienes and Essential Fatty Acids, December 1994, Elsevier

    Birgitta Strandvik

  177. 73 ELECTROGENIC ION TRANSPORT IN HUMAN DUODENUM

    Article • Journal of Pediatric Gastroenterology and Nutrition, October 1994, Wiley

    Birgitta Strandvik

  178. 74 EFFECTS OF LEUKOTRIENES ON ION TRANSPORT IN HUMAN DUODENUM

    Article • Journal of Pediatric Gastroenterology and Nutrition, October 1994, Wiley

    Birgitta Strandvik

  179. Inhibitory effects of theophylline, terbutaline, and hydrocortisone on leukotriene B4 and C4 generation by human leukocytes in vitro

    Article • Pediatric Pulmonology, September 1994, Wiley

    Professor Göran Wennergren, Birgitta Strandvik

  180. Bacterial colonisation withXanthomonas maltophilia — A retrospective study in a cystic fibrosis patient population

    Article • Infection, July 1994, Springer Science + Business Media

    Birgitta Strandvik

  181. Leukotriene B4and C4generation by blood leukocytes after ex vivo stimulation by Ca-ionophore and opsonized zymosan in children with atopic dermatitis

    Article • Pediatric Allergy and Immunology, May 1994, Wiley

    Professor Göran Wennergren, Birgitta Strandvik

  182. Bile salt sulphotransferase activity in the liver of cholestatic infants

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 1994, Taylor & Francis

    Birgitta Strandvik

  183. High doses of aminoglycosides did not produce liver toxicity in patients with cystic fibrosis

    Article • Journal of Hepatology, January 1994, Elsevier

    Birgitta Strandvik

  184. The urinary bile acid excretion in healthy premature and full-term infants during the neonatal period

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 1994, Taylor & Francis

    Birgitta Strandvik

  185. Effects of Different Formula Feeds on the Developmental Pattern of Urinary Bile Acid Excretion in Infants

    Article • Journal of Pediatric Gastroenterology and Nutrition, January 1994, Wiley

    Birgitta Strandvik

  186. Effects of Pancreatic and Snake Venom Phospholipase A2 on the Generation of Leukotriene B4 and C4 by Human Leukocytes in Vitro

    Article • Pancreas, January 1994, Wolters Kluwer Health

    Birgitta Strandvik

  187. Cystic Fibrosis Is Treatment with Ursodeoxycholic Acid of Value?

    Article • Scandinavian Journal of Gastroenterology, January 1994, Taylor & Francis

    Birgitta Strandvik

  188. Leukotriene B<sub>4</sub> and C<sub>4</sub> Generation by Small Intestinal Mucosa in Children with Coeliac Disease

    Article • Digestion, January 1994, Karger Publishers

    Birgitta Strandvik

  189. Leukotriene B4 generation by blood polymorphonuclear leukocytes after incubation in urine

    Article • Prostaglandins Leukotrienes and Essential Fatty Acids, October 1993, Elsevier

    Birgitta Strandvik

  190. Immunoglobulin G antibodies toPseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with cystic fibrosis or bacteremia

    Article • European Journal of Clinical Microbiology & Infectious Diseases, June 1993, Springer Science + Business Media

    Birgitta Strandvik

  191. Frequency of four cystic fibrosis mutations in a Swedish population

    Article • Acta Paediatrica, June 1993, Wiley

    Birgitta Strandvik

  192. Nephrolithiasis in cystic fibrosis

    Article • Acta Paediatrica, March 1993, Wiley

    Birgitta Strandvik

  193. Leukotriene B4 and C4 Generation by Human Colostral Macrophages in vitro

    Article • Neonatology, January 1993, Karger Publishers

    Birgitta Strandvik

  194. Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.

    Article • Antimicrobial Agents and Chemotherapy, November 1992, ASM Journals

    Birgitta Strandvik

  195. Capacity of Small Intestinal Mucosa to Produce Leukotriene B4 and C4 in Children with Celiac Disease

    Article • Journal of Pediatric Gastroenterology and Nutrition, November 1992, Wiley

    Birgitta Strandvik

  196. 6 ACCUMULATION OF IRON IN LIVERS FROM RATS DEFICIENT IN ESSENTIAL FATTY ACIDS (EFA);

    Article • Journal of Pediatric Gastroenterology and Nutrition, October 1992, Wiley

    Birgitta Strandvik

  197. 73 LEUKOTRIENE B4 and C4 GENERATION IN SMALL INTESTINAL MUCOSA OF CHILDREN WITH COELIAC DISEASE

    Article • Journal of Pediatric Gastroenterology and Nutrition, October 1992, Wiley

    Birgitta Strandvik

  198. Incorporation of dietary [14C]arachidonic acid and [3H]eicosapentaenoic acid into tissue lipids during absorption of a fish oil emulsion.

    Article • Journal of Lipid Research, September 1992, Elsevier

    Birgitta Strandvik

  199. Bile-duct destruction and collagen deposition: A prominent ultrastructural feature of the liver in cystic fibrosis

    Article • Hepatology, August 1992, Wiley

    Birgitta Strandvik

  200. The effect of essential fatty acid deficiency on hepatic bile salt sulphotransferase in rats

    Article • The Journal of Steroid Biochemistry and Molecular Biology, July 1992, Elsevier

    Birgitta Strandvik

  201. Erythrocyte Sodium-Potassium Transport in Cystic Fibrosis

    Article • Pediatric Research, May 1992, Springer Science + Business Media

    Birgitta Strandvik

  202. Serum Primary Bile Acids in the Course of Celiac Disease in Children

    Article • Journal of Pediatric Gastroenterology and Nutrition, May 1992, Wiley

    Birgitta Strandvik

  203. Craniofacial morphology in children with cystic fibrosis

    Article • European Journal of Orthodontics, April 1992, Oxford University Press (OUP)

    Birgitta Strandvik

  204. Home intravenous antibiotic treatment of patients with cystic fibrosis

    Article • Acta Paediatrica, April 1992, Wiley

    Birgitta Strandvik

  205. Long-term double-blind study on the influence of dietary fibres on faecal bile acid excretion in juvenile ulcerative colitis

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 1992, Taylor & Francis

    Birgitta Strandvik

  206. Liver Transplantation in a Boy with Acute Porphyria Due to Aminolaevulinate Dehydratase Deficiency

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 1992, De Gruyter

    Birgitta Strandvik

  207. The fertility potential of male cystic fibrosis patients

    Article • International Journal of Andrology, December 1991, Wiley

    Birgitta Strandvik

  208. Faecal bile acid excretion in children with inflammatory bowel disease.

    Article • Gut, November 1991, BMJ

    Birgitta Strandvik

  209. ABSORPTION AND METABOLISM OF 3H-EICOSAPENTAENOIC (EPA) AND 14C-ARACHIDONIC (AA) ACIDS IN NORMAL AND ESSENTIAL FATTY ACID (EFA) DEFICIENT RATS

    Article • Journal of Pediatric Gastroenterology and Nutrition, October 1991, Wiley

    Birgitta Strandvik

  210. A simplified analysis of fatty acids in serum phospholipids using Sep-Pak cartridges

    Article • Clinica Chimica Acta, August 1991, Elsevier

    Birgitta Strandvik

  211. Decreased Renal Clearance of Sodium in Cystic Fibrosis

    Article • Acta Paediatrica, February 1991, Wiley

    Birgitta Strandvik

  212. Serum Bile Acids in Relation to Disease Activity and Intake of Dietary Fibers in Juvenile Ulcerative Colitis

    Article • Digestion, January 1991, Karger Publishers

    Birgitta Strandvik

  213. Adaptive regulation of lipoprotein lipase and salt-resistant lipase activities in essential fatty acid deficiency: An experimental study in the rat

    Article • Metabolism, December 1990, Elsevier

    Birgitta Strandvik

  214. Renal Function in Rats with Essential Fatty Acid Deficiency

    Article • Clinical Science, October 1990, Portland Press Ltd.

    Birgitta Strandvik

  215. Pancreatic function in the essential fatty acid deficient rat

    Article • Metabolism, August 1990, Elsevier

    Birgitta Strandvik

  216. Absorption and metabolism of [3H]arachidonic and [14C]linoleic acid in essential fatty acid-deficient rats

    Article • AJP Gastrointestinal and Liver Physiology, July 1990, American Physiological Society

    Birgitta Strandvik

  217. Passive smoking in cystic fibrosis

    Article • Respiratory Medicine, July 1990, Elsevier

    Birgitta Strandvik

  218. Metabolism of [3H]arachidonic acid- and [14C]linoleic acid-labelled chylomicrons in essential fatty acid-deficient rats

    Article • Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, May 1990, Elsevier

    Birgitta Strandvik

  219. Prospective study of mycobacterial infections in patients with cystic fibrosis.

    Article • Thorax, May 1990, BMJ

    Birgitta Strandvik

  220. Antistaphylococcal antibodies in cystic fibrosis

    Article • Infection, May 1990, Springer Science + Business Media

    Birgitta Strandvik

  221. Phenobarbital Can Aggravate a Cholestatic Bile Acid Pattern in Infants with Obstructive Cholangiopathy

    Article • Journal of Pediatric Gastroenterology and Nutrition, April 1990, Wiley

    Birgitta Strandvik

  222. Increased Renal Clearance of Cefsulodin Due to Higher Glomerular Filtration Rate in Cystic Fibrosis

    Article • Clinical Pharmacokinetics, February 1990, Springer Science + Business Media

    Birgitta Strandvik

  223. Ketonic bile acids in urine of infants during the neonatal period.

    Article • Journal of Lipid Research, December 1989, Elsevier

    Birgitta Strandvik

  224. Relation between Essential Fatty Acid Metabolism and Gastrointestinal Symptoms in Cystic Fibrosis

    Article • Acta Paediatrica, November 1989, Wiley

    Birgitta Strandvik

  225. PANCREATIC FUNCTION IN ESSENTIAL FATTY ACID DEFICIENT (EFAD) RATS

    Article • Pediatric Research, September 1989, Springer Science + Business Media

    Birgitta Strandvik

  226. Effect on renal function of essential fatty acid supplementation in cystic fibrosis

    Article • The Journal of Pediatrics, August 1989, Elsevier

    Birgitta Strandvik

  227. Na, K-ATPase Activity in Rectal Mucosa of Children with Ulcerative Colitis and Crohn's Disease

    Article • Scandinavian Journal of Gastroenterology, January 1989, Taylor & Francis

    Birgitta Strandvik

  228. Serum and sputum concentrations of netilmicin in combination with acylureidopenicillin and cephalosporins in clinical treatment of pulmonary exacerbations in cystic fibrosis

    Article • Journal of Antimicrobial Chemotherapy, January 1989, Oxford University Press (OUP)

    Birgitta Strandvik

  229. Increased bronchial chloride concentration in cystic fibrosis

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 1989, Taylor & Francis

    Birgitta Strandvik

  230. Increased nonrenal clearance and increased diuretic efficiency of furosemide in cystic fibrosis

    Article • Clinical Pharmacology & Therapeutics, October 1988, Wiley

    Birgitta Strandvik

  231. 93 FECAL BILE ACID (BA) EXCRETION IN CHILDREN WITH INFLAMMATORYDISEASE (IBD)

    Article • Pediatric Research, September 1988, Springer Science + Business Media

    Birgitta Strandvik

  232. 96 ABSORPTION AND LIVER UPTAKE OF 3H-ARACHIDONIC ACID AND C-LINOLEIC ACID IN ESSENTIAL FATTY ACID DEFICIENT (EFAD) RATS

    Article • Pediatric Research, September 1988, Springer Science + Business Media

    Birgitta Strandvik

  233. 95 ARACHIDONIC ACID RELEASE AND ESSENTIAL FATTY ACID DEFICIENCY IN CYSTIC FIBROSIS

    Article • Pediatric Research, September 1988, Springer Science + Business Media

    Birgitta Strandvik

  234. 77 PHENOBARBITAL (P) INCREASES CHOLESTASIS IN LIVER DISEASE – A HAZARD TO INFANTS?

    Article • Pediatric Research, September 1988, Springer Science + Business Media

    Birgitta Strandvik

  235. Discussion

    Article • CHEST Journal, August 1988, Elsevier

    Birgitta Strandvik

  236. Composition and surface properties of the bronchial lipids in adult patients with cystic fibrosis

    Article • Clinica Chimica Acta, August 1988, Elsevier

    Birgitta Strandvik

  237. DEFECTIVE BILE ACID AMIDATION: PREDICTED FEATURES OF A NEW INBORN ERROR OF METABOLISM

    Article • The Lancet, August 1988, Elsevier

    Birgitta Strandvik

  238. Antibiotic Therapy of Pulmonary Infections in Cystic Fibrosis

    Article • CHEST Journal, August 1988, Elsevier

    Birgitta Strandvik

  239. Antibiotic therapy of pulmonary infections in cystic fibrosis. Dosage schedules and duration of treatment

    Article • CHEST Journal, August 1988, Elsevier

    Birgitta Strandvik

  240. Influence of the Glomerular Filtration Rate on Renal Clearance of Ceftazidime in Cystic Fibrosis

    Article • Clinical Pharmacokinetics, July 1988, Springer Science + Business Media

    Birgitta Strandvik

  241. 3-OXO-Δ4 BILE ACIDS IN LIVER DISEASE

    Article • The Lancet, June 1988, Elsevier

    Birgitta Strandvik

  242. HAEMORRHAGIC PANCREATITIS AFTER ERCP IN PATIENTS WITH ALPHA1-ANTITRYPSIN DEFICIENCY

    Article • The Lancet, April 1988, Elsevier

    Birgitta Strandvik

  243. Reply

    Article • The Journal of Pediatrics, March 1988, Elsevier

    Birgitta Strandvik

  244. Imipenem/cilastatin, an alternative treatment of pseudomonas infection in cystic fibrosis

    Article • Journal of Antimicrobial Chemotherapy, January 1988, Oxford University Press (OUP)

    Birgitta Strandvik

  245. Food Intake in Patients with Cystic Fibrosis on an Ordinary Diet

    Article • Scandinavian Journal of Gastroenterology, January 1988, Taylor & Francis

    Birgitta Strandvik

  246. Home Intravenous Antibiotic Treatment in Cystic Fibrosis

    Article • Scandinavian Journal of Gastroenterology, January 1988, Taylor & Francis

    Birgitta Strandvik

  247. Relation between Defective Regulation of Arachidonic Acid Release and Symptoms in Cystic Fibrosis

    Article • Scandinavian Journal of Gastroenterology, January 1988, Taylor & Francis

    Birgitta Strandvik

  248. Sclerosing Cholangitis in Cystic Fibrosis

    Article • Scandinavian Journal of Gastroenterology, January 1988, Taylor & Francis

    Birgitta Strandvik

  249. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis

    Article • Journal of Clinical Microbiology, October 1987, ASM Journals

    Birgitta Strandvik

  250. Prospective study of serum staphylococcal antibodies in cystic fibrosis.

    Article • Archives of Disease in Childhood, September 1987, BMJ

    Birgitta Strandvik

  251. Granulocyte elastase-α1-antiproteinase complex in cystic fibrosis: Sensitive plasma assay for monitoring pulmonary infections

    Article • The Journal of Pediatrics, August 1987, Elsevier

    Birgitta Strandvik

  252. Relation between clinical and roentgenological scores and measures of lung function in cystic fibrosis, with special reference to pulmonary Xenon133 elimination

    Article • Clinical Physiology and Functional Imaging, August 1987, Wiley

    Birgitta Strandvik

  253. 2. SCLEROSING CHOLANGITIS IN CYSTIC FIBROSIS

    Article • Pediatric Research, July 1987, Springer Science + Business Media

    Birgitta Strandvik

  254. Psychosocial Stressors and Gastrointestinal Disorders in Childhood and Adolescense

    Article • Scandinavian Journal of Gastroenterology, January 1987, Taylor & Francis

    Birgitta Strandvik

  255. Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect.

    Article • Proceedings of the National Academy of Sciences, December 1986, Proceedings of the National Academy of Sciences

    Birgitta Strandvik

  256. Morphological findings in the liver of children with cystic fibrosis: A light and electron microscopical study

    Article • Hepatology, September 1986, Wiley

    Birgitta Strandvik

  257. Absence of prostaglandins in semen of men with cystic fibrosis is an indication of the contribution of the seminal vesicles

    Article • Reproduction, September 1986, Bioscientifica

    Birgitta Strandvik

  258. Conformity of bacterial growth in sputum and contamination free endobronchial samples in patients with cystic fibrosis.

    Article • Thorax, August 1986, BMJ

    Birgitta Strandvik

  259. LIVER DAMAGE IN JUVENILE INFLAMMATORY BOWEL DISEASE

    Article • Pediatric Research, July 1986, Springer Science + Business Media

    Birgitta Strandvik

  260. Physical activity and self treatment in cystic fibrosis.

    Article • Archives of Disease in Childhood, April 1986, BMJ

    Birgitta Strandvik

  261. Increased mole fraction of arachidonic acid in bronchial phospholipids in patients with cystic fibrosis

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 1986, Taylor & Francis

    Birgitta Strandvik

  262. Antibodies to Staphylococcal Teichoic Acid and Alpha Toxin in Patients with Cystic Fibrosis

    Article • Acta Paediatrica, January 1986, Wiley

    Birgitta Strandvik

  263. In vivo and vitro studies on formation of bile acids in patients with Zellweger syndrome. Evidence that peroxisomes are of importance in the normal biosynthesis of both cholic and chenodeoxycholic acid.

    Article • Journal of Clinical Investigation, December 1985, American Society for Clinical Investigation

    Birgitta Strandvik

  264. Relation between antibody response to pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis

    Article • Pediatric Pulmonology, September 1985, Wiley

    Birgitta Strandvik

  265. Nutritional status in children receiving home parenteral nutrition

    Article • The Journal of Pediatrics, August 1985, Elsevier

    Birgitta Strandvik

  266. Unsuccessful Attempts to Induce Peroxisomes in Two Cases of Zellweger Disease by Treatment with Clofibrate

    Article • Pediatric Research, June 1985, Springer Science + Business Media

    Birgitta Strandvik

  267. 638 NUTRITION STATUS INF ED AND UNDFED CHILDREN RECEIVING HOME PARENTERAL

    Article • Pediatric Research, April 1985, Springer Science + Business Media

    Birgitta Strandvik

  268. Fasting Serum Bile Acid Levels in Relation to Liver Histopathology in Cystic Fibrosis

    Article • Scandinavian Journal of Gastroenterology, January 1985, Taylor & Francis

    Birgitta Strandvik

  269. Relation between Antibody Response to Pseudomonas aeruginosa Exoproteins and Colonization/Infection in Patients with Cystic Fibrosis

    Article • Acta Paediatrica, November 1984, Wiley

    Michael Vasil, Birgitta Strandvik

  270. Urinary excretion of dicarboxylic acids from patients with the zellweger syndrome Importance of peroxisomes in β-oxidation of dicarboxylic acids

    Article • Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, August 1984, Elsevier

    Birgitta Strandvik

  271. Persistent Tyrosinemia Associated with Low Activity of Tyrosine Aminotransferase

    Article • Pediatric Research, July 1984, Springer Science + Business Media

    Birgitta Strandvik

  272. ADVERSE REACTIONS TO PIPERACILLIN IN PATIENTS WITH CYSTIC FIBROSIS

    Article • The Lancet, June 1984, Elsevier

    Birgitta Strandvik

  273. Urinary excretion of tetrahydroxylated bile acids in children with α1-antitrypsin deficiency and neonatal cholestasis

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 1984, Taylor & Francis

    Birgitta Strandvik

  274. Prospective Study of Fatty Acid Supplementation Over 3 Years in Patients with Cystic Fibrosis

    Article • Journal of Pediatric Gastroenterology and Nutrition, August 1983, Wiley

    Birgitta Strandvik

  275. DIFFERENCE IN RENAL HANDLING OF CEFSULODIN BETWEEN PATIENTS WITH CYSTIC FIBROSIS AND NORMAL SUBJECTS

    Article • Acta Paediatrica, March 1983, Wiley

    Birgitta Strandvik

  276. Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis

    Article • Journal of Antimicrobial Chemotherapy, January 1983, Oxford University Press (OUP)

    Birgitta Strandvik

  277. Alpha-1-antitrypsin deficiency and juvenile liver disease Ultrastructural observations compared with light microscopy and routine liver tests

    Article • Virchows Archiv B Cell Pathology Including Molecular Pathology, January 1983, Springer Science + Business Media

    Birgitta Strandvik

  278. Serum Bile Acids as Markers of Juvenile Liver Disease in α1-Antitrypsin Deficiency

    Article • Journal of Pediatric Gastroenterology and Nutrition, December 1982, Wiley

    Birgitta Strandvik

  279. LIVER DISEASE IN CHILDREN WITH ALPHA1-ANTITRYPSIN DEFICIENCY WITHOUT NEONATAL CHOLESTASIS

    Article • Acta Paediatrica, November 1982, Wiley

    Birgitta Strandvik

  280. NATURAL HISTORY OF CHILDREN WITH ALPHA1‐ANTITRYPSIN DEFICIENCY AND NEONATAL CHOLESTASIS

    Article • Acta Paediatrica, November 1982, Wiley

    Birgitta Strandvik

  281. Urinary excretion of bile alcohols in normal children and patients with α1‐antitrypsin deficiency during development of liver disease

    Article • European Journal of Clinical Investigation, October 1982, Wiley

    Birgitta Strandvik

  282. RENAL FUNCTION IN CYSTIC FIBROSIS WITH SPECIAL REFERENCE TO THE RENAL SODIUM HANDLING

    Article • Acta Paediatrica, September 1982, Wiley

    Birgitta Strandvik

  283. Tetrahydroxylated bile acids in healthy human newborns

    Article • European Journal of Clinical Investigation, August 1982, Wiley

    Birgitta Strandvik

  284. BILE ACID METABOLISM IN LOW BIRTHWEIGHT INFANTS

    Article • Acta Paediatrica, July 1982, Wiley

    Birgitta Strandvik

  285. RENAL DISTURBANCE IN CYSTIC FIBROSIS

    Article • The Lancet, April 1982, Elsevier

    Birgitta Strandvik

  286. THE FIRST INFANT TO SURVIVE A GENERALIZED BCG INFECTION

    Article • Acta Paediatrica, January 1982, Wiley

    Birgitta Strandvik

  287. RENAL FUNCTION IN CYSTIC FIBROSIS

    Article • Pediatric Research, August 1980, Springer Science + Business Media

    Birgitta Strandvik

  288. Excretion of bile acids in healthy children and children with cystic fibrosis

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 1980, Taylor & Francis

    Birgitta Strandvik

  289. Urinary Bile Acid Excretion in Correlation to Liver Histopathology in Cystic Fibrosis

    Article • Scandinavian Journal of Gastroenterology, January 1980, Taylor & Francis

    Birgitta Strandvik

  290. METABOLISM OF LITHOCHOLIC ACID‐24–14C IN EXTRAHEPATIC BILIARY ATRESIA

    Article • Acta Paediatrica, January 1974, Wiley

    Birgitta Strandvik

  291. URINARY BILE ACID CONJUGATES IN EXTRAHEPATIC BILIARY ATRESIA

    Article • Acta Paediatrica, January 1974, Wiley

    Birgitta Strandvik

  292. BILE ACID EXCRETION AFTER DISAPPEARANCE OF JAUNDICE IN INTRAHEPATIC CHOLESTASIS OF INFANCY

    Article • Acta Paediatrica, May 1973, Wiley

    Birgitta Strandvik

  293. EXCRETION OF BILE ACIDS IN EXTRAHEPATIC BILIARY ATRESIA AND INTRAHEPATIC CHOLESTASIS OF INFANCY

    Article • Acta Paediatrica, May 1973, Wiley

    Birgitta Strandvik

  294. EXCRETION OF BILE ACIDS IN ERYTHROBLASTOSIS FOETALIS

    Article • Acta Paediatrica, March 1973, Wiley

    Birgitta Strandvik

  295. BILE ACIDS AND PANCREATIC ENZYMES DURING ABSORPTION IN THE NEWBORN

    Article • Acta Paediatrica, September 1972, Wiley

    Birgitta Strandvik

  296. Excretion of 3β-hydroxy-5-cholenoic and 3a-hydroxy-5a-cholanoic acids in urine of infants with biliary atresia

    Article • FEBS Letters, June 1971, Wiley

    Birgitta Strandvik

  297. TEST‐MEAL IN THE DIAGNOSIS OF MALABSORPTION IN INFANCY

    Article • Acta Paediatrica, March 1971, Wiley

    Birgitta Strandvik

  298. INTRAVENOUS GLUCOSE TOLERANCE IN OVERWEIGHT NEWBORN INFANTS AND THEIR MOTHERS

    Article • PEDIATRICS, April 1970, American Academy of Pediatrics (AAP)

    Birgitta Strandvik

  299. BILE ACID EXCRETION AND MALABSORPTION IN INTRAHEPATIC CHOLESTASIS OF INFANCY (“NEONATAL HEPATITIS”)

    Article • Acta Paediatrica, January 1969, Wiley

    Birgitta Strandvik

  300. AMAUROSIS AFTER BROXYQUINOLINE

    Article • The Lancet, April 1968, Elsevier

    Birgitta Strandvik

  301. Hepatobiliary Disease in Cystic Fibrosis

    Article • Wiley

    Birgitta Strandvik